Patent cliff causes negative outlook for global pharma | Healthcare Finance News
- tombird5
- Nov 1, 2012
- 1 min read
The outlook for the global pharmaceutical industry remains negative as any potential revenue over the next 12-18 months is likely to be offset by losses from the upcoming expirations of major patents - known as the patent cliff - according to a new industry report by Moody’s Investors Service.
Comments